APA (7th ed.) Citation

Mengual, L., Frantzi, M., Mokou, M., Ingelmo-Torres, M., Vlaming, M., Merseburger, A. S., . . . Van der Heijden, A. G. (2022). Multicentric validation of diagnostic tests based on BC-116 and BC-106 urine peptide biomarkers for bladder cancer in two prospective cohorts of patients. British Journal of Cancer, 127(11), 2043. https://doi.org/10.1038/s41416-022-01992-3

Chicago Style (17th ed.) Citation

Mengual, Lourdes, et al. "Multicentric Validation of Diagnostic Tests Based on BC-116 and BC-106 Urine Peptide Biomarkers for Bladder Cancer in Two Prospective Cohorts of Patients." British Journal of Cancer 127, no. 11 (2022): 2043. https://doi.org/10.1038/s41416-022-01992-3.

MLA (9th ed.) Citation

Mengual, Lourdes, et al. "Multicentric Validation of Diagnostic Tests Based on BC-116 and BC-106 Urine Peptide Biomarkers for Bladder Cancer in Two Prospective Cohorts of Patients." British Journal of Cancer, vol. 127, no. 11, 2022, p. 2043, https://doi.org/10.1038/s41416-022-01992-3.